Fluorine in PDB 8u8a: Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
Enzymatic activity of Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
All present enzymatic activity of Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib:
2.7.11.1;
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
(pdb code 8u8a). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib, PDB code: 8u8a:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 8u8a
Go back to
Fluorine Binding Sites List in 8u8a
Fluorine binding site 1 out
of 6 in the Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F2601
b:57.0
occ:1.00
|
F1
|
B:0LI2601
|
0.0
|
57.0
|
1.0
|
C19
|
B:0LI2601
|
1.3
|
53.8
|
1.0
|
F2
|
B:0LI2601
|
2.1
|
55.3
|
1.0
|
F3
|
B:0LI2601
|
2.2
|
54.8
|
1.0
|
C17
|
B:0LI2601
|
2.3
|
48.6
|
1.0
|
C16
|
B:0LI2601
|
3.0
|
46.9
|
1.0
|
CD1
|
B:LEU1927
|
3.2
|
79.9
|
1.0
|
C20
|
B:0LI2601
|
3.2
|
47.7
|
1.0
|
C18
|
B:0LI2601
|
3.4
|
47.8
|
1.0
|
CD1
|
B:LEU1932
|
4.3
|
53.6
|
1.0
|
CD2
|
B:LEU1985
|
4.3
|
65.3
|
1.0
|
CD2
|
B:LEU1932
|
4.3
|
56.7
|
1.0
|
C15
|
B:0LI2601
|
4.4
|
48.5
|
1.0
|
N3
|
B:0LI2601
|
4.5
|
53.6
|
1.0
|
CG
|
B:LEU1927
|
4.7
|
79.7
|
1.0
|
C13
|
B:0LI2601
|
4.7
|
46.2
|
1.0
|
CG
|
B:LEU1932
|
4.7
|
52.2
|
1.0
|
CD1
|
B:LEU1985
|
4.7
|
62.3
|
1.0
|
C21
|
B:0LI2601
|
4.8
|
51.3
|
1.0
|
CB
|
B:LEU1932
|
4.8
|
48.4
|
1.0
|
CD2
|
B:LEU1924
|
4.9
|
65.5
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 8u8a
Go back to
Fluorine Binding Sites List in 8u8a
Fluorine binding site 2 out
of 6 in the Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F2601
b:55.3
occ:1.00
|
F2
|
B:0LI2601
|
0.0
|
55.3
|
1.0
|
C19
|
B:0LI2601
|
1.3
|
53.8
|
1.0
|
F1
|
B:0LI2601
|
2.1
|
57.0
|
1.0
|
F3
|
B:0LI2601
|
2.1
|
54.8
|
1.0
|
C17
|
B:0LI2601
|
2.4
|
48.6
|
1.0
|
C16
|
B:0LI2601
|
3.2
|
46.9
|
1.0
|
C20
|
B:0LI2601
|
3.3
|
47.7
|
1.0
|
C18
|
B:0LI2601
|
3.4
|
47.8
|
1.0
|
C21
|
B:0LI2601
|
3.8
|
51.3
|
1.0
|
CE1
|
B:TYR1992
|
3.8
|
81.0
|
1.0
|
CD1
|
B:TYR1992
|
3.9
|
82.1
|
1.0
|
N3
|
B:0LI2601
|
4.1
|
53.6
|
1.0
|
CD1
|
B:LEU1985
|
4.3
|
62.3
|
1.0
|
C15
|
B:0LI2601
|
4.5
|
48.5
|
1.0
|
CB
|
B:ASP2017
|
4.5
|
57.7
|
1.0
|
CD2
|
B:LEU1932
|
4.6
|
56.7
|
1.0
|
CG2
|
B:ILE2015
|
4.6
|
44.2
|
1.0
|
N
|
B:ASP2017
|
4.7
|
57.9
|
1.0
|
C13
|
B:0LI2601
|
4.7
|
46.2
|
1.0
|
CZ
|
B:TYR1992
|
4.8
|
81.9
|
1.0
|
CG
|
B:TYR1992
|
4.8
|
82.1
|
1.0
|
C
|
B:ALA2016
|
5.0
|
53.7
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 8u8a
Go back to
Fluorine Binding Sites List in 8u8a
Fluorine binding site 3 out
of 6 in the Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F2601
b:54.8
occ:1.00
|
F3
|
B:0LI2601
|
0.0
|
54.8
|
1.0
|
C19
|
B:0LI2601
|
1.3
|
53.8
|
1.0
|
F2
|
B:0LI2601
|
2.1
|
55.3
|
1.0
|
F1
|
B:0LI2601
|
2.2
|
57.0
|
1.0
|
C17
|
B:0LI2601
|
2.3
|
48.6
|
1.0
|
C18
|
B:0LI2601
|
2.6
|
47.8
|
1.0
|
C16
|
B:0LI2601
|
3.7
|
46.9
|
1.0
|
O
|
B:ILE2015
|
3.9
|
48.4
|
1.0
|
C13
|
B:0LI2601
|
4.0
|
46.2
|
1.0
|
CD2
|
B:LEU1932
|
4.1
|
56.7
|
1.0
|
C
|
B:ILE2015
|
4.4
|
42.3
|
1.0
|
CB
|
B:LEU1932
|
4.4
|
48.4
|
1.0
|
CA
|
B:ALA2016
|
4.4
|
48.8
|
1.0
|
C20
|
B:0LI2601
|
4.5
|
47.7
|
1.0
|
O1
|
B:0LI2601
|
4.6
|
51.8
|
1.0
|
N
|
B:ASP2017
|
4.6
|
57.9
|
1.0
|
N
|
B:ILE1933
|
4.7
|
46.8
|
1.0
|
N
|
B:ALA2016
|
4.7
|
49.7
|
1.0
|
CG
|
B:LEU1932
|
4.7
|
52.2
|
1.0
|
C15
|
B:0LI2601
|
4.8
|
48.5
|
1.0
|
CD1
|
B:LEU1927
|
4.9
|
79.9
|
1.0
|
N2
|
B:0LI2601
|
4.9
|
44.5
|
1.0
|
CA
|
B:LEU1932
|
4.9
|
48.1
|
1.0
|
C
|
B:ALA2016
|
4.9
|
53.7
|
1.0
|
CD2
|
B:LEU1924
|
4.9
|
65.5
|
1.0
|
C14
|
B:0LI2601
|
4.9
|
47.0
|
1.0
|
CD1
|
B:LEU1932
|
5.0
|
53.6
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 8u8a
Go back to
Fluorine Binding Sites List in 8u8a
Fluorine binding site 4 out
of 6 in the Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F2601
b:60.1
occ:1.00
|
F1
|
C:0LI2601
|
0.0
|
60.1
|
1.0
|
C19
|
C:0LI2601
|
1.3
|
57.2
|
1.0
|
F2
|
C:0LI2601
|
2.1
|
58.0
|
1.0
|
F3
|
C:0LI2601
|
2.2
|
58.0
|
1.0
|
C17
|
C:0LI2601
|
2.3
|
52.5
|
1.0
|
C16
|
C:0LI2601
|
3.0
|
50.8
|
1.0
|
CD1
|
C:LEU1927
|
3.2
|
80.4
|
1.0
|
C20
|
C:0LI2601
|
3.2
|
52.2
|
1.0
|
C18
|
C:0LI2601
|
3.4
|
51.5
|
1.0
|
CD1
|
C:LEU1932
|
4.3
|
55.2
|
1.0
|
CD2
|
C:LEU1985
|
4.3
|
67.0
|
1.0
|
CD2
|
C:LEU1932
|
4.4
|
57.7
|
1.0
|
C15
|
C:0LI2601
|
4.4
|
51.6
|
1.0
|
N3
|
C:0LI2601
|
4.5
|
56.9
|
1.0
|
CG
|
C:LEU1927
|
4.7
|
80.2
|
1.0
|
C13
|
C:0LI2601
|
4.7
|
50.1
|
1.0
|
CG
|
C:LEU1932
|
4.7
|
53.3
|
1.0
|
CD1
|
C:LEU1985
|
4.7
|
64.0
|
1.0
|
C21
|
C:0LI2601
|
4.8
|
54.1
|
1.0
|
CB
|
C:LEU1932
|
4.8
|
49.5
|
1.0
|
CD2
|
C:LEU1924
|
4.9
|
66.2
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 8u8a
Go back to
Fluorine Binding Sites List in 8u8a
Fluorine binding site 5 out
of 6 in the Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F2601
b:58.0
occ:1.00
|
F2
|
C:0LI2601
|
0.0
|
58.0
|
1.0
|
C19
|
C:0LI2601
|
1.3
|
57.2
|
1.0
|
F1
|
C:0LI2601
|
2.1
|
60.1
|
1.0
|
F3
|
C:0LI2601
|
2.1
|
58.0
|
1.0
|
C17
|
C:0LI2601
|
2.4
|
52.5
|
1.0
|
C16
|
C:0LI2601
|
3.1
|
50.8
|
1.0
|
C20
|
C:0LI2601
|
3.3
|
52.2
|
1.0
|
C18
|
C:0LI2601
|
3.4
|
51.5
|
1.0
|
C21
|
C:0LI2601
|
3.8
|
54.1
|
1.0
|
CE1
|
C:TYR1992
|
3.8
|
82.5
|
1.0
|
CD1
|
C:TYR1992
|
3.9
|
83.8
|
1.0
|
N3
|
C:0LI2601
|
4.1
|
56.9
|
1.0
|
CD1
|
C:LEU1985
|
4.3
|
64.0
|
1.0
|
C15
|
C:0LI2601
|
4.5
|
51.6
|
1.0
|
CB
|
C:ASP2017
|
4.5
|
57.6
|
1.0
|
CD2
|
C:LEU1932
|
4.6
|
57.7
|
1.0
|
CG2
|
C:ILE2015
|
4.6
|
45.0
|
1.0
|
N
|
C:ASP2017
|
4.7
|
57.3
|
1.0
|
C13
|
C:0LI2601
|
4.7
|
50.1
|
1.0
|
CZ
|
C:TYR1992
|
4.8
|
83.0
|
1.0
|
CG
|
C:TYR1992
|
4.8
|
83.3
|
1.0
|
C
|
C:ALA2016
|
5.0
|
53.9
|
1.0
|
CD2
|
C:LEU1985
|
5.0
|
67.0
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 8u8a
Go back to
Fluorine Binding Sites List in 8u8a
Fluorine binding site 6 out
of 6 in the Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Cryo-Em Structure of LRRK2 Bound to Type II Inhibitor Ponatinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F2601
b:58.0
occ:1.00
|
F3
|
C:0LI2601
|
0.0
|
58.0
|
1.0
|
C19
|
C:0LI2601
|
1.3
|
57.2
|
1.0
|
F2
|
C:0LI2601
|
2.1
|
58.0
|
1.0
|
F1
|
C:0LI2601
|
2.2
|
60.1
|
1.0
|
C17
|
C:0LI2601
|
2.3
|
52.5
|
1.0
|
C18
|
C:0LI2601
|
2.6
|
51.5
|
1.0
|
C16
|
C:0LI2601
|
3.7
|
50.8
|
1.0
|
O
|
C:ILE2015
|
3.9
|
48.2
|
1.0
|
C13
|
C:0LI2601
|
4.0
|
50.1
|
1.0
|
CD2
|
C:LEU1932
|
4.1
|
57.7
|
1.0
|
C
|
C:ILE2015
|
4.4
|
42.6
|
1.0
|
CA
|
C:ALA2016
|
4.4
|
48.5
|
1.0
|
CB
|
C:LEU1932
|
4.4
|
49.5
|
1.0
|
C20
|
C:0LI2601
|
4.5
|
52.2
|
1.0
|
O1
|
C:0LI2601
|
4.6
|
55.3
|
1.0
|
N
|
C:ASP2017
|
4.6
|
57.3
|
1.0
|
N
|
C:ILE1933
|
4.7
|
47.4
|
1.0
|
N
|
C:ALA2016
|
4.7
|
49.1
|
1.0
|
CG
|
C:LEU1932
|
4.7
|
53.3
|
1.0
|
C15
|
C:0LI2601
|
4.8
|
51.6
|
1.0
|
CD1
|
C:LEU1927
|
4.9
|
80.4
|
1.0
|
N2
|
C:0LI2601
|
4.9
|
48.5
|
1.0
|
C
|
C:ALA2016
|
4.9
|
53.9
|
1.0
|
CA
|
C:LEU1932
|
4.9
|
49.0
|
1.0
|
CD2
|
C:LEU1924
|
4.9
|
66.2
|
1.0
|
C14
|
C:0LI2601
|
4.9
|
50.5
|
1.0
|
CD1
|
C:LEU1932
|
5.0
|
55.2
|
1.0
|
|
Reference:
H.Zhu,
P.Hixson,
W.Ma,
J.Sun.
Pharmacology of LRRK2 with Type I and II Kinase Inhibitors Revealed By Cryo-Em. Cell Discov V. 10 10 2024.
ISSN: ESSN 2056-5968
PubMed: 38263358
DOI: 10.1038/S41421-023-00639-8
Page generated: Sat Aug 3 00:48:58 2024
|